By rray, 23 August, 2023 Exclude Patient Type Detail Header No Detail Type Text Detail Text Individuals 60 yo w PSA 75 yo w PSA NCCN says very healthy pts 75 yo w little or no comorbidity esp if they ve never had PSA testing or if their PSA is rising 2B PSA AUA May d c screening or substantially lengthen rescreening interval for pts 75 yo if PSA If PSA 4 ng mL or very suspicious DRE bx and further w u indicated 2A 12 Validated risk calculators may be used to inform shared decision making process for prostate bx CR AUA B 6 AUA Use age specific cut thresholds 6 nbsp nbsp Age 40 49 yo 2 5 ng mL nbsp nbsp Age 50 59 yo 3 5 ng mL nbsp nbsp Age 60 69 yo 4 5 ng mL nbsp nbsp Age 70 79 yo 6 5 ng mL Rescreen interval or d c of screening based on pt preference age PSA prostate CA risk life expectancy and general health following shared decision making CR AUA B 6 Patient Type Detail Header (Long) If screened at age >75 yo, rescreen interval and bx guidance: